8374 Federal Register / Vol. 75, No. 36 / Wednesday, February 24, 2010 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Human Genome Research 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Human 

Genome Research Institute Special Emphasis 

Panel, Revolutionary Sequencing 

Technology. 

Date: April 2, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crystal City Marriott at Regan 

National Airport, 1999 Jefferson Davis 

Highway, Arlington, VA 22202. 

Contact Person: Ken D. Nakamura, PhD, 

Scientific Review Officer, Scientific Review 

Branch, National Human Genome Research 

Institute, National Institutes of Health, 5635 

Fishers Lane, Suite 4076, MSC 9306, 

Rockville, MD 20852, 301–402–0838, 

nakamurk@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.172, Human Genome 

Research, National Institutes of Health, HHS) 

Dated: February 17, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–3736 Filed 2–23–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, New 

Invertebrate Models for the Biology of Aging. 

Date: March 18, 2010. 

Time: 8:30 a.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites Hotel, Chevy Chase 

Pavilion, 4300 Military Road, NW., Bethesda, 

MD 20892. 

Contact Person: Elaine Lewis, PhD, 

Scientific Review Officer, Scientific Review 

Branch, National Institute on Aging, Gateway 

Building, Suite 2C212, MSC–9205, 7201 

Wisconsin Avenue, Bethesda, MD 20892. 

301–402–7707. elainelewis@nia.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, ADNI2. 

Date: March 30, 2010. 

Time: 1 p.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Suite 2C212, Bethesda, MD 20892. 

(Telephone Conference Call.) 

Contact Person: Elaine Lewis, PhD, 

Scientific Review Officer, Scientific Review 

Branch, National Institute on Aging, Gateway 

Building, Suite 2C212, MSC–9205, 7201 

Wisconsin Avenue, Bethesda, MD 20892. 

301–402–7707. elainelewis@nia.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, Behavioral 

Economics, Health and Aging. 

Date: March 31, 2010. 

Time: 9 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Suite 2C212, Bethesda, MD 20892. 

(Telephone Conference Call.) 

Contact Person: Rebecca J. Ferrell, PhD, 

Scientific Review Officer, National Institute 

on Aging, Gateway Building 2C212, 7201 

Wisconsin Avenue, Bethesda, MD 20892. 

301–402–7703. ferrellrj@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: February 17, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–3695 Filed 2–23–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–1566–CN] 

Medicare Program; Meeting of the 

Practicing Physicians Advisory 

Council, March 8, 2010; Correction 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Correction of notice. 

SUMMARY: This document corrects 

technical errors that appeared in the 

meeting notice published in the Federal 

Register on Friday, January 22, 2010 

entitled ‘‘Medicare Program; Meeting of 

the Practicing Physicians Advisory 

Council, March 8, 2010.’’ 

FOR FURTHER INFORMATION CONTACT: 

Kelly Buchanan, DFO, (410) 786–6132, 

or e-mail PPAC_hhs@cms.hhs.gov. 

News media representatives must 

contact the CMS Press Office, (202) 690– 

6145. Please refer to the CMS Advisory 

Committees’ Information Line (1–877– 

449–5659 toll free), (410) 786–9379 

local) or the Internet at http:// 

www.cms.hhs.gov/home/ 

regsguidance.asp for additional 

information and updates on committee 

activities. 

SUPPLEMENTARY INFORMATION: 

I. Background 

In FR Doc. 2010–1333 of January 22, 

2010 (75 FR 3743), there were a number 

of technical errors that are identified 

and corrected in the ‘‘Correction of 

Errors’’ section below. 

II. Summary of Errors 

In section III. of the notice, ‘‘Meeting 

Registration and Security Information’’, 

we inadvertently included security 

information for the Hubert H. 

Humphrey building instead of the CMS 

central office. Therefore, we are 

removing section III. in its entirety and 

replacing the language as noted in 

section III. of this notice. 

III. Correction of Errors 

In FR Doc. 2010–1333 of January 22, 

2010 (75 FR 3743), replace section III. in 

its entirety with the following language: 

III. Meeting Registration and Security 

Information 

The meeting is open to the public, but 

attendance is limited to the space available. 

Persons wishing to attend this meeting must 

register by contacting the DFO at the address 

listed in the ADDRESSES section of this notice 

or by telephone at the number listed in the 

FOR FURTHER INFORMATION CONTACT section of 

this notice by the date specified in the DATES

section of this notice. 


pwalker on DSK8KYBLC1PROD with NOTICES
Federal Register / Vol. 75, No. 36 / Wednesday, February 24, 2010 / Notices 8375 

Individuals requiring sign language 

interpretation or other special 

accommodations must contact the DFO via 

the contact information specified in the FOR

FURTHER INFORMATION CONTACT section of this 

notice by the date listed in the DATES section 

of this notice. 

This meeting will be held in a Federal 

government building; therefore, Federal 

security measures are applicable. We 

recommend that confirmed registrants arrive 

reasonably early, but no earlier than 45 

minutes prior to the start of the meeting, to 

allow additional time to clear security. 

Security measures include the following: 

• Presentation of government-issued 

photographic identification to the Federal 

Protective Service or Guard Service 

personnel. 

• Inspection of vehicle’s interior and 

exterior (this includes engine and trunk 

inspection) at the entrance to the grounds. 

Parking permits and instructions will be 

issued after the vehicle inspection. 

• Inspection, via metal detector or other 

applicable means of all persons brought 

entering the building. We note that all items 

brought into CMS, whether personal or for 

the purpose of presentation or to support a 

presentation, are subject to inspection. We 

cannot assume responsibility for 

coordinating the receipt, transfer, transport, 

storage, set-up, safety, or timely arrival of any 

personal belongings or items used for 

presentation or to support a presentation. 

Note: Individuals who are not registered in 

advance will not be permitted to enter the 

building and will be unable to attend the 

meeting. The public may not enter the 

building earlier than 45 minutes prior to the 

convening of the meeting. 

All visitors must be escorted in areas other 

than the lower and first floor levels in the 

Central Building. 

Authority: (Section 1868 of the Social 

Security Act (42 U.S.C. 1395ee) and section 

10(a) of Pub. L. 92–463 (5 U.S.C. App. 2, 

section 10(a)).) 

Dated: February 18, 2010. 

Charlene Frizzera, 

Acting Administrator, Centers for Medicare 

& Medicaid Services. 

[FR Doc. 2010–3693 Filed 2–19–10; 4:15 pm] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2010–N–0080] 

Device Improvements to Reduce 

Unnecessary Radiation Exposure From 

Medical Imaging; Public Meeting; 

Request for Comments 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of public meeting; 

request for comments. 

The Food and Drug Administration 

(FDA) is announcing a public meeting 

entitled: ‘‘Device Improvements to 

Reduce Unnecessary Radiation 

Exposure From Medical Imaging.’’ The 

purpose of this meeting is to discuss 

steps that could be taken by 

manufacturers of devices used in 

computed tomography (CT) and in 

fluoroscopy that would help reduce 

unnecessary patient exposure to 

ionizing radiation during CT and 

fluoroscopic procedures. FDA is seeking 

input on this topic and requests 

comments on a number of related 

questions. 

Dates and Time: The public meeting 

will be held on March 30 and 31, 2010, 

from 8 a.m. to 5 p.m. Persons interested 

in attending and/or participating in the 

meeting must register by 5 p.m. on 

March 15, 2010. Submit written or 

electronic comments by April 15, 2010. 

Location: The public meeting will be 

held at the Holiday Inn Gaithersburg, 2 

Montgomery Village Ave., Gaithersburg, 

MD 20879. The meeting will not be 

videotaped or webcast. 

Contact Person: Simon Choi, Food 

and Drug Administration, Center for 

Devices and Radiological Health, Food 

and Drug Administration, 10903 New 

Hampshire Ave., Bldg. 66, rm. 5400, 

Silver Spring, MD 20993–0002, 301– 

796–5426, e-mail: 

simon.choi@fda.hhs.gov. 

Registration: If you wish to attend the 

public meeting, you must register by emailing CDRHimaging

initiative@fda.hhs.gov. Provide 

complete contact information for each 

attendee, including name, title, 

company or organization, address, email, and telephone number. 

Registration requests must be received 

by March 15, 2010. 

If you wish to make an oral 

presentation during any of the sessions 

at the meeting (see section II of this 

document, Public Meeting), you must 

indicate this at the time of registration. 

FDA has included specific questions for 

comment in section III of this document, 

Questions for Comment. You should 

also identify the session(s) during which 

you would like to present, as well as the 

question(s) you would like to address in 

each session. In order to keep each 

session focused on the topic at hand, 

presentations given during each session 

should address only the topic specified 

for that session. FDA will do its best to 

accommodate requests to speak. 

Individuals and organizations with 

common interests are urged to 

consolidate or coordinate their 

presentations, and to request time for a 

joint presentation. FDA will determine 

the amount of time allotted to each 

presenter and the approximate time that 

each oral presentation is scheduled to 

begin. 

If you would like to participate in any 

of the four planned roundtable 

discussions (see section II of this 

document, Public Meeting), you must 

indicate this interest at the time of 

registration, and also submit a brief 

statement that describes your 

experience with CT or fluoroscopic 

devices. FDA is seeking participants 

interested in engaging in one of four 

wrap-up roundtable discussions related 

to the presentations given during each 

of the earlier sessions of the meeting. 

Each roundtable discussion will include 

no more than 10 nonFDA participants. 

Only one participant from an 

organization or company will be 

assigned to each discussion group. FDA 

will attempt to have a range of 

constituencies represented in each 

discussion group. Others in attendance 

at the public meeting will have an 

opportunity to listen to each roundtable 

discussion. 

Registration is free and will be on a 

first-come, first-served basis. Early 

registration is recommended because 

seating is limited. FDA may limit the 

number of participants from each 

organization based on space limitations. 

Registrants will receive confirmation 

once they have been accepted. Onsite 

registration on the day of the public 

meeting will be provided on a spaceavailable basis beginning at 7 a.m. 

If you need special accommodations 

due to a disability, please contact Simon 

Choi at 301–796–5426, 

simon.choi@fda.hhs.gov at least 7 days 

in advance of the meeting. 

Comments: FDA is holding this public 

meeting to obtain information on a 

number of questions regarding steps 

manufacturers of CT and fluoroscopic 

devices could take to help reduce 

unnecessary patient exposure to 

ionizing radiation from these medical 

imaging modalities. The deadline for 

submitting comments related to this 

public meeting is April 15, 2010. 

Regardless of attendance at the public 

meeting, interested persons may submit 

written or electronic comments. Submit 

written comments to the Division of 

Dockets Management (HFA–305), Food 

and Drug Administration, 5630 Fishers 

Lane, rm. 1061, Rockville, MD 20852. 

Submit electronic comments to http:// 

www.regulations.gov. Submit a single 

copy of electronic comments or two 

paper copies of any mailed comments, 

except that individuals may submit one 

paper copy. Comments are to be 

identified with the docket number 

found in brackets in the heading of this 

document. In addition, when 


pwalker on DSK8KYBLC1PROD with NOTICES